Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acis Bio is a biotechnology company and contract research organization (CRO) based in California that specializes in the production of high-quality recombinant proteins and antibodies. The company provides a wide range of custom services, including protein expression, purification, and assay development, to support drug discovery and life science research. Acis Bio offers expertise across various expression systems, such as mammalian, insect, and bacterial platforms, to meet the specific needs of its pharmaceutical and academic clients. In addition to its service offerings, the company maintains a catalog of off-the-shelf reagents and biological products. By focusing on technical excellence and rapid turnaround times, Acis Bio serves as a key partner for organizations looking to outsource complex protein engineering and production tasks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acis.